Evidence for a strong Graft-versus-Leukemia (GvL) effect against the HLA-AZ-restricted minor histocompatibility antigen (mHag) HA-1 after donor lymphocyte infusion (DLI)

被引：0

|

作者：

Eibl, B

Stevanovic, S

Grünewald, K

Mitterschiffthaler, A

Rammensee, HG

Gastl, G

Nachbaur, D

机构：

来源：

BONE MARROW TRANSPLANTATION | 2001年 / 27卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

收藏

页码：S22 / S23

页数：2

相关论文

共 22 条

[1] Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion
Kircher, B
Wolf, M
Stevanovic, S
Rammensee, HG
Grubeck-Loebenstein, B
Gastl, G
Nachbaur, D
JOURNAL OF IMMUNOTHERAPY, 2004, 27 (02): : 156 - 160
[2] Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients
T Mutis
R Brand
D Gallardo
A van Biezen
D Niederwieser
E Goulmy
Leukemia, 2010, 24 : 1388 - 1392
[3] Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients
Mutis, T.
Brand, R.
Gallardo, D.
van Biezen, A.
Niederwieser, D.
Goulmy, E.
LEUKEMIA, 2010, 24 (07) : 1388 - 1392
[4] Minor histocompatibility antigen HA-1-specific T-cells and graft-versus-leukemia activity following DLI
Kircher, B
Wolf, M
Stevanovic, S
Rammensee, HG
Grubeck-Loebenstein, B
Gastl, G
Nachbaur, D
BONE MARROW TRANSPLANTATION, 2003, 31 : S121 - S122
[5] Induction of hematopoiesis-specific minor histocompatibility antigen (mHag) HA-1 and HA-2 specific CD8+T-cells after Donor Lymphocyte Infusion (DLI) for relapsed CML associated with complete molecular remission
Marijt, WAF
Kester, MGDM
Goulmy, E
Mutis, T
Drijfhout, JW
Willemze, R
Falkenburg, JHF
BONE MARROW TRANSPLANTATION, 2001, 27 : S23 - S24
[6] Emergence of hematopoiesis-specific minor histocompatibility antigen (mHag) HA-1 and HA-2 specific CD8+T cells associated with complete molecular remission after donor lymphocyte infusion (DLI) for relapsed CML.
Marijt, WAF
Kester, MGD
Goulmy, E
Mutis, T
Drijfhout, JW
Willemze, R
Falkenburg, JHF
BLOOD, 2000, 96 (11) : 478A - 478A
[7] Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: Usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion
Nakao, S
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 274 - 276
[8] Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: Usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion
Shinji Nakao
International Journal of Hematology, 2002, 76 : 274 - 276
[9] Induction of graft-versus-leukemia (GVL) effects by donor lymphocyte infusions (DLI) after non-myeloablative conditioning: Evidence for loss of GVL reactivity over time.
Mapara, MY
Kim, YM
Sykes, M
BLOOD, 2000, 96 (11) : 311B - 311B
[10] Minor histocompatibility antigens (mHag) HA-1 and HA-2 specific cytotoxic T-cells (CTL) induce complete remissions (CR) after donor lymphocyte infusion (DLI) for relapsed CML or multiple myeloma (MM) after allogeneic stem cell transplantation (alloSCT)
Marijt, WAF
Heemskerk, MHM
Hoogeboom, M
de Paus, RA
Goulmy, EAJM
Kester, MGD
van der Hoom, MAWG
Drijfhout, JW
Willemze, R
Falkenburg, JHF
BONE MARROW TRANSPLANTATION, 2002, 29 : S2 - S3